[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate

C46H80O3 — CID 162909963

IUPAC[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate
SMILESC=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C[C@H](O)CCCCCCCCCCCCC)C(C)(C)[C@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C46H80O3/c1-10-11-12-13-14-15-16-17-18-19-20-21-34(47)32-40(48)49-39-26-28-44(7)37(42(39,4)5)25-29-46(9)38(44)23-22-36-41-35(33(2)3)24-27-43(41,6)30-31-45(36,46)8/h34-39,41,47H,2,10-32H2,1,3-9H3/t34-,35+,36-,37-,38-,39+,41-,43-,44+,45-,46-/m1/s1
InChIKeyWBNRJAJHDJRUDM-PHXOORMMSA-N
MW681.14 g/mol
LogP13.03
Rot. Bonds16

About [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate

[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate (PubChem CID 162909963) has the molecular formula C46H80O3 and a molecular weight of 681.14 g/mol. Its IUPAC name is [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate.

Molecular Properties

Compound Name[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate
PubChem CID162909963
Molecular FormulaC46H80O3
Molecular Weight681.14 g/mol
Exact Mass680.61
IUPAC Name[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate
SMILESC=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C[C@H](O)CCCCCCCCCCCCC)C(C)(C)[C@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C46H80O3/c1-10-11-12-13-14-15-16-17-18-19-20-21-34(47)32-40(48)49-39-26-28-44(7)37(42(39,4)5)25-29-46(9)38(44)23-22-36-41-35(33(2)3)24-27-43(41,6)30-31-45(36,46)8/h34-39,41,47H,2,10-32H2,1,3-9H3/t34-,35+,36-,37-,38-,39+,41-,43-,44+,45-,46-/m1/s1
InChIKeyWBNRJAJHDJRUDM-PHXOORMMSA-N
XLogP13.03
TPSA46.53 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds16
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500681.14
LogP ≤ 513.03
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate?
The IUPAC name of [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate (CID 162909963) is [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate.
What is the SMILES notation for [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate?
The canonical SMILES for [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate is C=C(C)[C@@H]1CC[C@]2(C)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C[C@H](O)CCCCCCCCCCCCC)C(C)(C)[C@H]5CC[C@]43C)[C@@H]12.
What is the InChIKey of [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate?
The InChIKey is WBNRJAJHDJRUDM-PHXOORMMSA-N. The full InChI is InChI=1S/C46H80O3/c1-10-11-12-13-14-15-16-17-18-19-20-21-34(47)32-40(48)49-39-26-28-44(7)37(42(39,4)5)25-29-46(9)38(44)23-22-36-41-35(33(2)3)24-27-43(41,6)30-31-45(36,46)8/h34-39,41,47H,2,10-32H2,1,3-9H3/t34-,35+,36-,37-,38-,39+,41-,43-,44+,45-,46-/m1/s1.
What are the key properties of [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate?
[(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate has a molecular weight of 681.14 g/mol, XLogP of 13.03, 16 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,3aR,5aR,5bR,7aS,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (3R)-3-hydroxyhexadecanoate is sourced from PubChem (CID 162909963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).